ISDA

Deposition Date 2012-12-13

Release Date 2013-04-17

Last Version Date 2024-02-28

Entry Detail

PDB ID:

4IDV

Keywords:

Transferase/Transferase Inhibitor

Title:

Crystal Structure of NIK with compound 4-{3-[2-amino-5-(2-methoxyethoxy)pyrimidin-4-yl]-1H-indol-5-yl}-2-methylbut-3-yn-2-ol (13V)

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.90 Å

R-Value Free:

0.26

R-Value Work:

0.20

R-Value Observed:

0.20

Space Group:

P 21 21 21

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Mitogen-activated protein kinase kinase kinase 14
Gene (Uniprot):MAP3K14
Chain IDs:A, B, C, D
Chain Length:356
Number of Molecules:4
Biological Source:Homo sapiens

UniProt ID:Q99558 Pfam ID:PF00069

Ligand Molecules

13V

Primary Citation

Inhibiting NF-KB-inducing kinase (NIK): Discovery, structure-based design, synthesis, structure activity relationship, and co-crystal structures

Li, K, McGee, L.R, Fisher, B, Sudom, A, Liu, J, Rubenstein, S.M, Anwer, M.K, Cushing, T.D, Shin, Y, Ayres, M, Lee, F, Eksterowicz, J, Faulder, P, Waszkowycz, B, Plotnikova, O, Farrelly, E, Xiao, S.H, Chen, G, Wang, Z.Show

Bioorg.Med.Chem.Lett. 23 1238 1244 (2013)

PMID: 23374866 DOI: 10.1016/j.bmcl.2013.01.012

Abstact

The discovery, structure-based design, synthesis, and optimization of NIK inhibitors are described. Our work began with an HTS hit, imidazopyridinyl pyrimidinamine 1. We utilized homology modeling and conformational analysis to optimize the indole scaffold leading to the discovery of novel and potent conformationally constrained inhibitors such as compounds 25 and 28. Compounds 25 and 31 were co-crystallized with NIK kinase domain to provide structural insights.

Legend

Protein

Chemical

Disease

Primary Citation of related structures